Analysis of vascularity in breast tumors - Comparison of high frequency ultrasound and contrast-enhanced color harmonic imaging;Vaskularisationsanalyse bei mammatumoren - Vergleich von hochfrequenzsonographie und Kontrast-Colour-Harmonic-Imaging

RoFo Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden Verfahren

Volumn 174, Issue 9, 2002, Pages 1132-1141

  Schröder, Ralf Jürgen ^a   Bostanjoglo, M ^a   Hidajat, N ^a   Rademaker, J ^a   Rottgen R ^a   Maurer J ^a   Felix, R ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Breast tumors; Color harmonic imaging; D galactose; Power Doppler; Ultrasound contrast agent

Indexed keywords

CONTRAST MEDIUM; SHU 508;

ADULT; ARTICLE; BREAST TUMOR; CLINICAL ARTICLE; COLOR HARMONIC IMAGING; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; ECHOGRAPHY; FEMALE; HIGH FREQUENCY ULTRASOUND; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; PRIORITY JOURNAL; QUALITATIVE DIAGNOSIS; QUANTITATIVE DIAGNOSIS; TUMOR VASCULARIZATION;

ADULT; AGED; BREAST NEOPLASMS; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMAGE ENHANCEMENT; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; POLYSACCHARIDES; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, DOPPLER, COLOR; ULTRASONOGRAPHY, MAMMARY;

EID: 0036740875     PISSN: 14389029     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-33940     Document Type: Article

References (38)

1. Steyaert L. Doppler sonography in breast pathology. JBR-BTR 2000; 83: 121-122
2. Mehta TS, Raza S, Baum JK. Use of Doppler ultrasound in the evaluation of brest carcinoma. Semin Ultrasound CT MR 2000; 21: 297-307
3. Sohn C, Beldermann F, Bastert G. Sonographic blood flow measurements in malignant breast tumors. A potential new prognostic factor. Surg Endosc 1997; 11: 957-960
4. Saarela AO, Rissanen TJ, Kiviniemi HO, Paloneva TK. Mammographic and ultrasonographic findings in bilateral brest cancer: a comparative study. Eur Radiol 1998; 8: 634-638
5. Baker JA, Soo MS. Th evolving role of sonography in evaluating solid breast masses. Semin Ultrasound CT MR 2000; 21: 286-296
6. Cosgrove D. Microbubble enhancement of tumor neovascularity. Eur Radiol 1999; 9: S413-S414
7. Ortega N, Sordello S, Plouet J. Tumoral vascularization: physiology and the therapeutic prospects. Bull Cancer 1997; 84: 391-395
8. Srivastava A, Hughes LE, Woodcock JP, Laidler P. Vascularity in cutaneous melanoma detected by Doppler sonography and histology: correlation with tumor behaviour. Br J Cancer 1989; 59: 89-91
9. Hartmann A, Kunz M, Kostlin S, Gillitzer R, Toksoy A, Brocker EB, Klein CE. Hypoxia induced up-regulation of angiogenin in human malignant melanoma. Caner Res 1999; 59: 1578-1583
10. Tur E, Brenner S. Cutaneous blood flow measurements for the detection of malignancy in pigmented skin lesions. Dermatology 1992; 184: 8-11
11. Delorme S. Beurteilung der Tumorvaskularisation mit der Dopplersonographie. Radiologe 1998; 38: 335-343
12. Burns P. Harmonic imaging. Angiology 1996; 7: S63-S74
13. Alexander AA, Nazarian LN, Capuzzi JrDM, Rawool NM, Kurtz AB, Mastrangelo MJ. Color Doppler sonographic detection of tumor flow in superficial melanoma metastases: histologic correlation. Ultrasound Med 1998; 17: 123-126
14. Ramos I, Taylor KJW, Kier R. Tumor vascular singles with neovascular morphologic features. Radiology 1988; 166: 57-62
15. Birdwell RL, Ikeda DM, Jeffrey SS, Jeffrey JrRB. Preliminary experience with power Doppler imaging of solid brest masses. Am J Roentgenol 1997; 169: 703-707
16. Kook SH, Park HW, Lee YR, Lee YU, Pae WK, Park YL. Evaluation of solid breast lesions with power Doppler sonography. J Clin Ultrasound 1999; 27: 231-237
17. Giuseppetti GM, Baldassarre S, Marconi E. Color Doppler sonography. Eur J Radiol 1998; 27 (2): S254-258
18. Lee WJ, Chu JS, Huang CS, Chang MF, Chang KJ, Chen KM. Breast cancer vascularity: color Doppler sonography and histopathology study. Breast Cancer Res Treat 1996; 37: 291-298
19. Youssefzadeh S, Eibenberger K, Helbvich T, Jakesz R, Wolf G. Use of resistance index for the diagnosis of breast tumors. Clin Radiol 1996; 51: 418-420
20. Chao TC, Lo YF, Chen SC, Chen MF. Color Doppler ultrasound in benign and malignant breast tumors. Brest Cancer Res Treat 1999; 57: 193-199
21. Schroeder RJ, Maeurer J, Vogl TJ, Hidajat N, Hadijuana J, Venz S, Weber S, Felix R. D-galactose-based signal-enhanced color Doppler sonography of breast tumors and tumorlike lesions. Invest Radiol 1999; 34: 109-115
22. Weind KL, Maier CF, Rutt BK, Moussa M. Invasive carcinomas and fibroadenomas of the breast: comparison of microvessel distributions - implications for imaging modalities. Radiology 1998; 208: 477-483
23. Buadu LD, Murakami J, Murayama S, Hashiguchi N, Toyoshima S, Sakai S, Yabuuchi H, Masuda K, Uroki S, Ohno S. Color Doppler sonography of breast masses: a multiparameter analysis. Clin Radiol 1997; 52: 917-923
24. Lee WJ, Chu JS, Houng SJ, Chung MF, Wang SM, Chen KM. Breast cancer angiogenesis: a quantitative morphologic and Doppler imaging study. Ann Surg Oncol 1995; 2: 246-251
25. Milz P, Lienemann A, Kessler M, Reiser M. Evaluation of breast lesions by power Doppler sonography. Eur Radiol 2001; 11: 547-554
26. Martinoli C, Pretolesi F, Crespi G, Bianchi S, Gandolfo N, Valle M, Derchi LE. Power Doppler sonography: clinical applications. Eur J Radiol 1999; 27 (2): S133-140
27. Lgalla R, Caruso G, Finazzo M. Monitoring treatment response with color and power Doppler. Eur J Radiol 1998; 27 (2): S149-156
28. Delorme S, Knopp MV. Non-invasive vascular imaging: assessing tumor vascularity. Eur Radiol 1998; 8: 517-527
29. Sehgal CM, ARger PH, Rowling SE, Conant EF, Reynolds C, Patton JA. Quantitative vascularity of breast masses by Doppler imaging: regional variations and diagnostic implications. J Ultrasound Med 2000; 19: 427-440
30. Stuhrmann M, Aronius R, Roefke C, Schietzel M. Vaskularisation von Mammatumoren: Einsatz des Ultraschallkontrastmittels in der Dignitätsbeurteilung. Vorläufige Ergebnisse. Fortschr Röntgenstr 1998; 169: 360-364
31. Stuhrmann M, Aronius R, Schietzel M. Tumor vascularity of breast lesions: potentials and limits of contrast-enhanced Doppler sonography. Am J Roentgenol 2000; 175: 1585-1589
32. Huber S, Stiskal M, Steinbach R, Czembirek H. Vaskularisation von Fibroadenomen: Kontrast-Harmonic-Imaging im Vergleich mit kontrastverstärktem Power Doppler. Fortschr Röntgenstr 2000; 172: 830-835
33. Chaudhari MH, Forsberg F, Voodarla A, Saikali FN, Goonewardene S, Needleman L, Finkel GC, Goldberg BB. Breast tumor vascularity identified by contrast enhanced ultrasound and pathology: initial results. Ultrasonics 2000; 38: 105-109
34. Moon WK, Im JG, Noh DY, Han MC. Nonpalpable breast lesions: evaluation with power Doppler US and a microbubble contrst agent - initial experience. Radiology 2000; 217: 240-246
35. Kedar RP, Cosgrove D, McCready VR, Bamber JC, Carter ER. Microbubble contrast agent for color Doppler US: effect on breast masses. Work in progress. Radiology 1996; 198: 679-686
36. Schroeder RJ, Hauff P, Bartels T, vogel K, Jeschke J, Hidajat T, Maeurer J. Tumor vascularization in experimental melanoms: correlation between unenhanced and contrast enhanced power Doppler imaging and histological grading. Ultrsound Med Biol 2001; 27: 761-771
37. Biohmer JU, Oellinger H, Schmidt C, Hufnagl P, Felix R, Lichtenegger W. Comparison of various imaging methods with particular evaluation of color doppler sonography for planning surgery of breast tumors. Arch Gynecol Obstet 1999; 262: 159-171
38. Lee WJ, Chu JS, Chang Kj, Chen KM. Occult breast carcinoma - use of color Doppler in localization. Breast Cancer Res Treat 1996; 37: 299-302